# Thymosin-α1 for Recurrent Implantation Failure

> **NCT07675980** · PHASE2,PHASE3 · RECRUITING · sponsor: **Fakih IVF Fertility Center** · enrollment: 136 (estimated)

## Conditions studied

- Recurrent Implantation Faliure

## Interventions

- **DRUG:** Thymosin Alpha1
- **OTHER:** Placebo Control

## Key facts

- **NCT ID:** NCT07675980
- **Lead sponsor:** Fakih IVF Fertility Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-11
- **Primary completion:** 2027-02
- **Final completion:** 2027-06
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2026-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07675980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07675980, "Thymosin-α1 for Recurrent Implantation Failure". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07675980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*